Showing results (111-120 of 147) with videos related to
Sort By:
Pageof 15
Journal of Animal Science and Technology|April 24, 2023
Analysis of antibiotic resistance genes in pig feces during the weaning transition using whole metagenome shotgun sequencingGi Beom Keum, Eun Sol Kim, Jinho Cho, et al.Diabetologia|April 19, 2024
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trialJi Yoon Kim, Sang-Man Jin, Kang Hee Sim, et al.Journal of the American Heart Association|October 21, 2025
Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young AdultsJoonyub Lee, Minwoo Lee, Seung-Hwan Lee, et al.Diabetes, Obesity & Metabolism|January 19, 2021
Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance studyJaehyun Bae, Kee-Ho Song, Jong Suk Park, et al.Journal of Animal Science and Technology|November 16, 2023
Comparative analysis of the pig gut microbiome associated with the pig growth performanceJun Hyung Lee, San Kim, Eun Sol Kim, et al.Cardiovascular Therapeutics|February 22, 2018
Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practiceHyunah Kim, Hyeseon Lee, Tong Min Kim, et al.Journal of Diabetes and Its Complications|December 7, 2010
Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitusEun Sook Kim, Hyuk Sang Kwon, Chul Woo Ahn, et al.Diabetes Care|April 26, 2011
Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima-media thickness in type 2 diabetesEun Sook Kim, Sung-dae Moon, Hun-Sung Kim, et al.Diabetes Care|May 30, 2008
Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up studySeung-Hyun Ko, Shin-Ae Park, Jae-Hyoung Cho, et al.Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.Pageof 15